These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 2556080)
1. Inhibitory effects of quinolones on DNA gyrase of Escherichia coli and topoisomerase II of fetal calf thymus. Hoshino K; Sato K; Une T; Osada Y Antimicrob Agents Chemother; 1989 Oct; 33(10):1816-8. PubMed ID: 2556080 [TBL] [Abstract][Full Text] [Related]
2. Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases. Hoshino K; Sato K; Akahane K; Yoshida A; Hayakawa I; Sato M; Une T; Osada Y Antimicrob Agents Chemother; 1991 Feb; 35(2):309-12. PubMed ID: 1850968 [TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. Moreau NJ; Robaux H; Baron L; Tabary X Antimicrob Agents Chemother; 1990 Oct; 34(10):1955-60. PubMed ID: 1963290 [TBL] [Abstract][Full Text] [Related]
4. Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition. Hoshino K; Kitamura A; Morrissey I; Sato K; Kato J; Ikeda H Antimicrob Agents Chemother; 1994 Nov; 38(11):2623-7. PubMed ID: 7872758 [TBL] [Abstract][Full Text] [Related]
5. Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I. Tabary X; Moreau N; Dureuil C; Le Goffic F Antimicrob Agents Chemother; 1987 Dec; 31(12):1925-8. PubMed ID: 2830840 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of quinolones on murine hematopoietic progenitor cells and eukaryotic topoisomerase II. Akahane K; Hoshino K; Sato K; Kimura Y; Une T; Osada Y Chemotherapy; 1991; 37(3):224-6. PubMed ID: 1653684 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases. Takei M; Fukuda H; Yasue T; Hosaka M; Oomori Y Antimicrob Agents Chemother; 1998 Oct; 42(10):2678-81. PubMed ID: 9756776 [TBL] [Abstract][Full Text] [Related]
8. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis. Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV of Enterococcus faecalis. Onodera Y; Okuda J; Tanaka M; Sato K Antimicrob Agents Chemother; 2002 Jun; 46(6):1800-4. PubMed ID: 12019093 [TBL] [Abstract][Full Text] [Related]
10. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases. Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828 [TBL] [Abstract][Full Text] [Related]
11. DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity. Takahata M; Nishino T Antimicrob Agents Chemother; 1988 Aug; 32(8):1192-5. PubMed ID: 2847648 [TBL] [Abstract][Full Text] [Related]
12. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Tanaka M; Sato K; Kimura Y; Hayakawa I; Osada Y; Nishino T Antimicrob Agents Chemother; 1991 Jul; 35(7):1489-91. PubMed ID: 1656864 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of differential activities of ofloxacin enantiomers. Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280 [TBL] [Abstract][Full Text] [Related]
14. Induction of calf thymus topoisomerase II-mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A-65282. Kohlbrenner WE; Wideburg N; Weigl D; Saldivar A; Chu DT Antimicrob Agents Chemother; 1992 Jan; 36(1):81-6. PubMed ID: 1317151 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of quinolones against Escherichia coli DNA gyrase. Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200 [TBL] [Abstract][Full Text] [Related]
16. Activity of KB-5246 against outer membrane mutants of Escherichia coli and Salmonella typhimurium. Kotera Y; Inoue M; Mitsuhashi S Antimicrob Agents Chemother; 1990 Jul; 34(7):1323-5. PubMed ID: 2167038 [TBL] [Abstract][Full Text] [Related]
17. Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents. Barrett JF; Gootz TD; McGuirk PR; Farrell CA; Sokolowski SA Antimicrob Agents Chemother; 1989 Oct; 33(10):1697-703. PubMed ID: 2556075 [TBL] [Abstract][Full Text] [Related]
19. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones. Strahilevitz J; Robicsek A; Hooper DC Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor. Nakada N; Gmünder H; Hirata T; Arisawa M Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]